Spyre Therapeutics
SYRE
#2075
Rank
โ‚น822.52 B
Marketcap
โ‚น8,661
Share price
-4.26%
Change (1 day)
298.48%
Change (1 year)

EPS for Spyre Therapeutics (SYRE)

EPS in 2026 (TTM): -โ‚น262.57

According to Spyre Therapeutics's latest financial reports the company's current EPS (TTM) is -โ‚น259.95. In 2025 the company made an earnings per share (EPS) of -โ‚น190.41 an increase over its 2024 EPS that were of -โ‚น345.09.

EPS history for Spyre Therapeutics from 2024 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-โ‚น262.5737.9%
2025-โ‚น190.41-44.82%
2024-โ‚น345.09